newsfilter
← Latest News
ACCESS Newswire·

Amphastar Announces FDA Approval for Ipratropium Bromide HFA

RANCHO CUCAMONGA, CA / ACCESS Newswire / February 24, 2026 / Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved the Company's Abbreviated New Drug